1050392-29-4 Usage
General Description
3-(4-methoxyphenyl)-4-methylisothiazol-5-amine is a chemical compound that belongs to the isothiazolone class. It is commonly used as a preservative in various personal care products, such as shampoos, conditioners, and moisturizers. 3-(4-methoxyphenyl)-4-methylisothiazol-5-amine is known for its antimicrobial properties, which help prevent the growth of bacteria, fungi, and other microorganisms in these products, thereby extending their shelf life. However, it is important to note that 3-(4-methoxyphenyl)-4-methylisothiazol-5-amine can also be a skin irritant and allergen for some individuals, and therefore should be used with caution, especially in products that come in direct contact with the skin.
Check Digit Verification of cas no
The CAS Registry Mumber 1050392-29-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,0,3,9 and 2 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1050392-29:
(9*1)+(8*0)+(7*5)+(6*0)+(5*3)+(4*9)+(3*2)+(2*2)+(1*9)=114
114 % 10 = 4
So 1050392-29-4 is a valid CAS Registry Number.
InChI:InChI=1S/C11H12N2OS/c1-7-10(13-15-11(7)12)8-3-5-9(14-2)6-4-8/h3-6H,12H2,1-2H3
1050392-29-4Relevant articles and documents
3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity
Fisher, Matthew J.,Backer, Ryan T.,Barth, Vanessa N.,Garbison, Kim E.,Gruber, Joseph M.,Heinz, Beverly A.,Iyengar, Smriti,Hollinshead, Sean P.,Kingston, Anne,Kuklish, Steven L.,Li, Linglin,Nisenbaum, Eric S.,Peters, Steven C.,Phebus, Lee,Simmons, Rosa Maria A.,Van Der Aar, Ellen
, p. 2514 - 2517 (2012/05/05)
The disclosed 3-phenyl-5-isothiazole carboxamides are potent allosteric antagonists of mGluR1 with generally good selectivity relative to the related group 1 receptor mGluR5. Pharmacokinetic properties of a member of this series (1R,2R)-N-(3-(4-methoxyphenyl)-4-methylisothiazol-5-yl)-2- methylcyclopropanecarboxamide (14) are good, showing acceptable plasma and brain exposure after oral dosing. Oral administration of isothiazole 14 gave robust activity in the formalin model of persistent pain which correlated with CNS receptor occupancy.